Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib may help treat severe hair loss, but more research is needed.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Nasolabial skin-fat grafts are good for nasal reconstruction with minimal scarring and no need for bolsters, but smoking may affect graft survival.

PRP treatment improves hair density and thickness for alopecia, but needs more research.

Some Middle Eastern plants may help treat diabetes and could be alternatives to current drugs, but more research is needed.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

The document concludes that early diagnosis and treatment are crucial for children with hair loss to prevent permanent damage, although not all conditions can be effectively treated.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Minoxidil lowers blood pressure and increases heart efficiency, but may raise lung artery pressure in some people.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

Amitraz effectively treated sarcoptic mange in three alpacas.

Asiasari Radix et Rhizoma is safe and has potential for new drug development due to its therapeutic properties.

A 15-year-old with KID syndrome developed a rare skin condition called PEHFN.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

PRP therapy improves hair density and thickness in AGA patients, even with other treatments.